Results 101 to 110 of about 76,496 (274)

Orthotopic liver transplantation in human-immunodeficiency-virus-positive patients in Germany [PDF]

open access: yes, 2012
Objectives: This summary evaluates the outcomes of orthotopic liver transplantation (OLT) of HIV-positive patients in Germany. Methods: Retrospective chart analysis of HIV-positive patients, who had been liver-transplanted in Germany between July ...
Anadol, Evrim   +15 more
core   +2 more sources

In Memoriam: Prof. Dr. Michael P. Manns (1951–2025)

open access: yes
United European Gastroenterology Journal, EarlyView.
Heiner Wedemeyer, Markus Cornberg
wiley   +1 more source

A Focus on Natural Autophagy Modulators as Potential Host‐Directed Weapons Against Emerging and Re‐Emerging Viruses

open access: yesMedicinal Research Reviews, Volume 45, Issue 6, Page 1850-1882, November 2025.
ABSTRACT Autophagy is a highly conserved intracellular process involved in maintaining homeostasis and in the degradation of damaged organelles and external pathogens. Nature provides complex and varied reservoirs of scaffolds and chemical entities that may have a pivotal role in the search for new therapeutic leads.
Ilaria Cursaro   +5 more
wiley   +1 more source

Impact of IFN lambda 3/4 single nucleotide polymorphisms on the cytomegalovirus reactivation in autologous stem cell transplant patients [PDF]

open access: yes, 2018
Cytomegalovirus (CMV) infection represents one of the main cause mortality after Stem Cell Transplantation. Recently, a protective effect of the T allele of rs12979860 IL28B Single Nucleotide Polymorphisms (SNPs) against CMV infection in the allogenic ...
Angeletti, S   +13 more
core   +1 more source

Fabrication and evaluation of ribavirin-loaded electrospun nanofibers as an antimicrobial wound dressing

open access: yesSaudi Pharmaceutical Journal
Background: Skin is regarded as an essential first line of defense against harmful pathogens and it hosts an ecosystem of microorganisms that create a widely diverse skin microbiome.
Khulud A. Alsulami   +11 more
doaj   +1 more source

Ribavirin as a beneficial treatment option for hepatitis C virusassociated glomerular disease

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2020
The management of hepatitis C virus (HCV)-induced glomerular disease remains unsatisfactory despite novel advances in antiviral and immunosuppressive therapy.
Fabrizio Fabrizi   +7 more
doaj   +1 more source

Ribavirin therapy for Chikungunya arthritis

open access: yesJournal of Infection in Developing Countries, 2008
Chikungunya is an acute viral infection presenting with a febrile episode and severe arthralgia, swelling of soft tissues, especially around the ankles. Many patients recover with nonspecific treatment of analgesics. Some patients continue to have subacute crippling arthritis in the legs affecting their mobility.
Rajan Ravichandran, Manju Manian
openaire   +4 more sources

Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) [PDF]

open access: yes, 2016
This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source.
Al-Tawfiq, Jaffar A., Memish, Ziad A.
core   +1 more source

Significant Decline in HCV‐Related Mortality From Liver Cirrhosis and Chronic Liver Disease (2015–2022): A Sentinel Center Study

open access: yesLiver International, Volume 45, Issue 11, November 2025.
ABSTRACT Background Reducing mortality attributable to hepatitis C virus (HCV) is a key target in the World Health Organization (WHO) HCV elimination strategy. While liver cancer registration in Taiwan includes hepatitis C antibody (anti‐HCV) status, no national registry records viral etiologies for deaths from liver cirrhosis and chronic liver disease
Cheng‐Yeh Yang   +5 more
wiley   +1 more source

Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis C [PDF]

open access: yes, 2000
Background/Aims: Combination therapy with interferon-alpha (IFN-alpha) plus ribavirin is more efficacious than IFN-alpha monotherapy in previously untreated patients with chronic hepatitis C and patients with IFN-alpha relapse.
Berg, Thomas   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy